Loading...
Sight Sciences, Inc.
SGHT•NASDAQ
Healthcare
Medical - Devices
$3.49
$-0.07(-1.97%)
Sight Sciences, Inc. (SGHT) Financial Performance & Income Statement Overview
Review Sight Sciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.47%
↓ 1.47%
Operating Income Growth
11.77%
↑ 11.77%
Net Income Growth
7.27%
↑ 7.27%
Operating Cash Flow Growth
52.63%
↑ 52.63%
Operating Margin
-63.59%
↓ 63.59%
Gross Margin
85.66%
↑ 85.66%
Net Profit Margin
-63.24%
↓ 63.24%
ROE
-54.62%
↓ 54.62%
ROIC
-42.25%
↓ 42.25%
Sight Sciences, Inc. (SGHT) Income Statement & Financial Overview
Review Sight Sciences, Inc.'s (SGHT) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $19.07M | $20.16M | $21.37M | $19.27M |
| Cost of Revenue | $2.51M | $3.25M | $3.02M | $2.79M |
| Gross Profit | $16.56M | $16.91M | $18.34M | $16.47M |
| Gross Profit Ratio | $0.87 | $0.84 | $0.86 | $0.86 |
| R&D Expenses | $4.29M | $4.75M | $4.32M | $4.64M |
| SG&A Expenses | $24.20M | $23.39M | $26.68M | $26.56M |
| Operating Expenses | $28.49M | $28.14M | $31.00M | $31.20M |
| Total Costs & Expenses | $31.003M | $31.39M | $34.02M | $33.99M |
| Interest Income | $0.00 | $0.00 | $0.00 | $1.65M |
| Interest Expense | $1.16M | $1.15M | $1.15M | $1.20M |
| Depreciation & Amortization | $176000.00 | $158000.00 | $100000.00 | $192000.00 |
| EBITDA | -$10.47M | -$11.23M | -$11.07M | -$14.85M |
| EBITDA Ratio | -$0.55 | -$0.56 | -$0.52 | -$0.77 |
| Operating Income | -$11.93M | -$11.23M | -$12.65M | -$14.72M |
| Operating Income Ratio | -$0.63 | -$0.56 | -$0.59 | -$0.76 |
| Other Income/Expenses (Net) | $121000.00 | $329000.00 | $337000.00 | -$1.53M |
| Income Before Tax | -$11.81M | -$10.90M | -$12.31M | -$16.25M |
| Income Before Tax Ratio | -$0.62 | -$0.54 | -$0.58 | -$0.84 |
| Income Tax Expense | $38000.00 | $166000.00 | $15000.00 | $17000.00 |
| Net Income | -$11.85M | -$11.07M | -$12.33M | -$16.27M |
| Net Income Ratio | -$0.62 | -$0.55 | -$0.58 | -$0.84 |
| EPS | -$0.24 | -$0.22 | -$0.25 | -$0.33 |
| Diluted EPS | -$0.24 | -$0.22 | -$0.25 | -$0.33 |
| Weighted Avg Shares Outstanding | $50.80M | $50.34M | $49.90M | $49.49M |
| Weighted Avg Shares Outstanding (Diluted) | $50.80M | $50.34M | $49.90M | $49.49M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan